chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information regarding Flumist (2003-2004 Formula) (influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen)) was received from a healthcare professional regarding a 41 year old female pt who experienced pleurisy, inflammation, shortness of breath and chest pain.  At 41 years of age, the pt received a dose on 12/09/2003.  The pt who worked in the reporting physician's office, developed chest pain (chest pain) in the evening of 12/14/2003.  The next day, she was still complaining of chest pain and shortness of breath (dyspnoea).  An EKG was performed and it was abnormal.  The pt was given nitroglycerin every five minutes for three doses.  That same day, she was admitted to the hospital.  Her chest pain continued through the night.  She was diagnosed with pleurisy (pleurisy) and inflammation (inflammation).  On 12/16/2003, she was discharged from the hospital. Test Results: Electrocardiogram (results: abnormal) was done on 15-Dec-2003. Additionally, fibrin D dimer (results: increased) was done on an unspecified date. No additional information was available at the date of this report. Follow-up information received from the patient's physician provided event outcome and county where vaccine was administered. She recovered.
Pt received Janssen COVID vaccine. 4/2/21 at 12;20PM  After the injection pt was seated in a chair for observation.  Pt began feeling light headed and passed out.  Her eyes never closed and she did not fall from sitting in the chair.  She looked out of it for a brief period, 1-2 minutes.  Afterwards, pt stated she had a burning sensation and she felt week.  We gave the pt water and she agreed to stay in waiting area for 30 minutes.  Pt husband and daughter were with her while she was in waiting area. 911 was not called as pt was responding and began to feel better.  Pt observed for 30 minutes.  She stated she felt fine when she left the pharmacy with her husband and daughter.  Told pt to seek medical attention is symptoms persist or come back.
Raised red rash, Itchy, bumpy where injection, size of her hand.  located between shoulder and elbow.
Extreme pain radiating down arm I to hand.  Pain conti use to date.  Injection was unusually painful during administration.  Injection was given very high  - on top on shoulder.
Patient experienced syncope with drop in BP from initial 112/72 to 84/54, Pulse rate initially high 40's to 72 at discharge'; BP back to 102/66 at discharge. Oxygen 100% via pulse ox.
Swelling and redness that night he had the vaccine on 4/24/07. 11x9 cm Erythema induration. Ice pack to right arm. May give Motrin PRN for Pain.
h/a,abd cramps,forgetfulness;has post exposure series w/DEV @ least 23yrs ago,but still had detectable titer of 1:5;pt had mild UTI @ time of vax & was felt poss infect could be causing abd cramping & discomfort
pt recv vax 1FEB96 & 2FEB96 pt devel full body vesicles & a fever;MD felt the vesicle devel was d/t to vax;
Pain immediately after injection. About 5 hours later, severe headache and dizziness. Fatigue, and nausea. Went to sleep, woke up extremely cold and couldn?t get warm, went back to sleep woke up the next morning and felt fine and about 24 hours after the shot, started to feel sick again with dizziness, headache, fatigue and nausea.
sore arm; This is a spontaneous report from a contactable consumer. This case is for one of the 3 patients with same drug different events. This consumer reported for a 49-Year-old female patient who received first dose of BNT162B2 (COMIRNATY, Solution for injection, Lot number: Unknown), through an unspecified route on 14Apr2021 (age at vaccination: unknown) as single dose for COVID-19 immunization. The concomitant medication and medical history were not reported. The patient had sore arm and the outcome of the event was not reported.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
A pharmacist reported that pt developed a "significant" local reaction post vax. This is 1 of 5 pts from this facility who developed an adverse experience following receipt of Prevnar.
Very tired & intense joint pain all night. Next day, chills & flu like symptoms (a very upset stomach) After 48 hours, side effects disappeared completely.
Itching over chest and abdomen from collar to waist. Red raised rash noted. Some areas of rash are pustular. No redness or itching at injection site.
flu like, achy, back pain w/in 36hrs p/vax;sluggishness, bloating for 36hrs-pain moved to side myalgia, arthralgia 6 days total
Patient was given the incorrect vaccine (pediatric Pfizer instead of Pfizer 12+) at the clinic. The clinic was a majority of pediatric patients and the nurse did not double check with the patient for the age and requested vaccine before vaccinating the patient. The accident was quickly realized, and the patient was notified. At that time the clinic manager claimed that this was not a reportable error and would be an acceptable 2nd dose. The patient was informed of this and left the clinic without the correct 2nd dose. No adverse effects were experienced by the patient
Patient & mother report right arm (deltoid) 3" L x 3" W red, swollen, & warm to touch. 2" down from shoulder bone.
did not feel like eating; low energy; fatigue; This case was reported by a consumer via call center representative and described the occurrence of appetite absent in a 83-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced appetite absent, energy decreased and fatigue. On an unknown date, the outcome of the appetite absent, energy decreased and fatigue were unknown.   It was unknown if the reporter considered the appetite absent, energy decreased and fatigue to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The case was reported for reporter's son in law. The patient received Shingrix and experienced fatigue, low energy, and did not feel like eating. The dates and timing of onset unknow by the reporter. The reporter consented to follow up. This case was 3 of the 3 cases, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021063953:same reporter US-GLAXOSMITHKLINE-US2021063952:same reporter
The pt was institutionalized in a nursing home and received a Flurvirin injection on 11/5/01. The next evening, the pt complained of chest pain and right hand pain. He was given sublingual nitroglycerin with marginal relief and experienced increasing shortness of breath. Subsequently, the pt was transported to the hospital and was pronounced dead upon arrival on 11/6/01. The reporter stated that the pt may have experienced a massive myocardial infarction. The reporter has assessed the relationship of study medication to the event as unknown. Death certificate states cause of death to be coronary artery disease.
onset of Rhumatoid Arthritis - symptoms began 2 weeks after my 2nd vaccine and have worsened since then
18 y/o M with hx of anaphalaxysis with green peas and white beans noted throat scratchiness with no signs of wheezing, sob, syncope, near syncope, n/v, or angio edema. Patient alert and oriented, vital signs stable: HR 90, RR 16, BP 110/84, 99% O2 on Room air, airway patent, no rash visible. 25mg benedryl by mouth given. Symptoms resolved. Patient monitored 30 minutes in observation. Pt discharged in stable condition.
Information has been received from a pharmacist concerning a female in her sixties who on approximately 08-APR-2011, "2 weeks ago", was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and Lot # not reported). On approximately 19-APR-2011, "2-3 days ago", the patient developed pain "behind her knees". The patient called pharmacist to seek medical attention. At the time of the report, the status of the patient was not reported. Additional information has been requested.
She got her vaccines, it hurt to get stuck with the needle.  She started getting dizzy once she got home.  She read our brochure and she was either to call EMS or the doctor, but she did not.  She lied down and went to sleep and when she woke up she was sick as a dog from the top of her head to the bottom of her feet.  All of her muscles hurt, she had a can of chicken noodle soup that she could not eat.  She felt nauseous and threw up what little bit she ate, and then got a terrible headache.  She went back to sleep.   The next day she still not feel good.  She spent the day in bed, sleep, wake up and go back to sleep.  Again she was nauseous with dry heaves, headache.  On Thursday she spent half a day in bed, not a person to spend time in bed.  She decided to get up and move around and made herself get up.  She then  had weakness, dizziness, loss of cognitive thinking, not caring about anything anymore.  She is still weak but can walk if she stares straight ahead and not as dizzy as she was before.  She did not call her doctor or take anything for her symptoms.
Pt alert, oriented. Pt rcv'd J&J vaccine and approx 6 minutes later felt tingling in both of her hands. Pt reports hx of sesame seed allergic reaction (anaphylaxis), and she was concerned that this may progress to that point so she just wanted to be checked. Pt declines chest pain, diff breathing, dizziness, syncope, N/V, diaphoresis. Speaking in full sentences. V/S as shown. Pt remained in monitoring area until parking area was released.. Pt stated she felt better and left.
Chest pain for 2 hours, seen in Emergency Dept. Elevated Cardiac enzymes, suspect myocarditis
10/18/2016, I went to bathroom at 3:30 AM, as I was in proceed of sitting down on the commode, dizziness set in, lost balance and fell against the side of bath tub, hitting right side of back and hip, did not blackout, able to get up and return to bed, applying cold pack. Same thing happened again at 5:30 AM the room swirled, did not fall. Dizziness and nausea followed.
The patient received her COVID booster shot in her left deltoid muscle around 3:45pm on Friday 10/29/2021. The patient stated that she awoke the next morning (10/30/2021) with fever, chills, and body aches. She then stated that the area around the injection site became inflamed and warm to the touch as well as painful which progressed in intensity throughout the weekend. Patient states that she also had an inflamed lymph node in her l;eft armpit that was also tender to the touch. The patient went to her physician on 11/2/2021 and was prescribed mupirocin 2% ointment and fluocinonide 0.05% cream.
5 x 10cm red, swollen area (hive).  Almd immunization site (large local reaction).  Treated with Benadryl, Keflex (5 days).
Fever ache for one day. Ice-pick headache lasting almost 2 weeks with need of prescription medicine
Patient received Pfizer COVID vaccine on 6/23/21 and 7/14/21. On 1/18/22, patient admitted to our inpatient facility (med/surg unit) for diverticulosis (with bright red blood per rectum and melena) and was also found to be COVID positive during admission screening. On 1/19/22, patient was intubated and transferred to hospital with acute hypoxic respiratory failure due to hemorrhagic shock and acute blood loss anemia. As of today (1/21/22), patient is still intubated in hospital.
I woke up 7:00 AM feeling very nauseous, had joint pain in my legs, and a moderate headache. I vomited multiple times half an hour later. While my nausea went away by 11:00 AM, as of 3:00 PM I still have moderate joint pain, severe fatigue, and a moderate headache.
Pt recvd Hep B vax; Next day developed redness, heat & swelling approx 7.5" @ inject site; No further details were provided;
Having the feeling of a need to urinate, but inability to. A lot of pain in the groin area. High blood pressure. Diarhea all night.
REDNESS AT INJECTION SITE OF VARICELLA VACCINE, SIZE PALM OF HAND AND SOME DISCOMFORT
No adverse event; 2nd dose on 06Apr2021, 3rd dose on 05May2021, 4th dose on 01Jun2022/patient had 3 booster; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (2nd dose on 06Apr2021, 3rd dose on 05May2021, 4th dose on 01Jun2022/patient had 3 booster) and NO ADVERSE EVENT (No adverse event) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A, 036A21A, 017F21A and 037A22A) for COVID-19 prophylaxis.     The patient's past medical history included Magnesium low. Previously administered products included for Whooping cough: TETANUS VACCINE (2-3 years ago); for Hypothyroidism: Synthroid. Past adverse reactions to the above products included No adverse event with Synthroid and TETANUS VACCINE. Concurrent medical conditions included Raynaud's disease (Lupus spectrum), Fibromyalgia, Diabetes, Hypertension, Gene mutation and Clot blood.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-May-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Jun-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Jun-2022, the patient experienced EXTRA DOSE ADMINISTERED (2nd dose on 06Apr2021, 3rd dose on 05May2021, 4th dose on 01Jun2022/patient had 3 booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (2nd dose on 06Apr2021, 3rd dose on 05May2021, 4th dose on 01Jun2022/patient had 3 booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (2nd dose on 06Apr2021, 3rd dose on 05May2021, 4th dose on 01Jun2022/patient had 3 booster).    Concomitant medication was not reported. Patient had a gene mutation which predisposes her to blood clots (prothrombin II). Patient did not receive any other vaccines in the past 4 weeks before the 2nd bivalent dose. Patient administered 5th dose (bivalent) on 10Oct2022, lot number was 053D22A and 6th dose (bivalent) on 17May2023, lot number was AS7172B. Patient had the 2nd bivalent vaccine on 17May2023, and it was administered on the "inner fatty part of her upper shoulder". Patient went to pain management yesterday because she fell out of bed on 02Mar2023. They are prescribing prednisolone 4mg for 6 days.          Treatment drug was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-725233 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2023: Narrative updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-725233:BIVALENT
Received MENACTRA vaccine in her left arm on Tuesday 3/6/2018. That night, she developed redness and itching at the site which has become a little swollen and increasing size of redness. At time of evaluation on Thursday 3/8/2018, she had 1.5in x 1.5in round area of redness that is mildly swollen. No systemic signs of reaction.
Tested positive for Covid-19; Lack of drug effect; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 31-Dec-2021 and was forwarded to Moderna on 31-Dec-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for Covid-19) and DRUG INEFFECTIVE (Lack of drug effect) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006C2A and 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Dec-2021, the patient experienced COVID-19 (Tested positive for Covid-19) and DRUG INEFFECTIVE (Lack of drug effect). At the time of the report, COVID-19 (Tested positive for Covid-19) and DRUG INEFFECTIVE (Lack of drug effect) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Dec-2021, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant and treatment product use was provided. The patient tested COVID-19 positive. The patient was done with the 5 day isolation period and had no symptoms now wanted to get the booster dose.  This is a spontaneous case concerning a 33-year-old female patient with no medical history reported, who experienced the unexpected event of COVID-19, and drug ineffective. The event occurred approximately 8 months after the second dose of the mRNA  1273 vaccine. At the time of report outcome of events was still unknown. The reporter's assessment was not provided. The rechallenge is not applicable since there's no information provided about the first dose. The benefit-risk relationship of the vaccine is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This is a spontaneous case concerning a 33-year-old female patient with no medical history reported, who experienced the unexpected event of COVID-19, and drug ineffective. The event occurred approximately 8 months after the second dose of the mRNA  1273 vaccine. At the time of report outcome of events was still unknown. The reporter's assessment was not provided. The rechallenge is not applicable since there's no information provided about the first dose. The benefit-risk relationship of the vaccine is not affected by this report.
Approximately 3 days after receiving my first dose of the Pfizer vaccine, I began experiencing extreme anxiety, panic, fatigue, and intrusive thoughts, including suicidal ideation. The episode lasted approximately 2 days. I consulted with my therapist 2 days after the episode ended and sent a message to my primary care provider.
pt revd vax @ 9AM; nasal congestion @ 920AM; rapid heart rate 100-110 @ 10AM, dizziness, h/a, cont heart rate, elevated BP; rx given;
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 51-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter stated that the vaccine was stored in freezer, and they take out one to two vials and place in fridge each day as needed.  No concomitant medications were reported. No treatment information was reported.
Pain; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) and ARTHRALGIA (Joint pain) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN (Pain) and ARTHRALGIA (Joint pain). At the time of the report, PAIN (Pain) and ARTHRALGIA (Joint pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
pt recvd vax & devel pityriasis rosea; MD felt that appearance of pityriasis rosea in reference to the vax was coincidental; No further details were provided;
pt recv vax & devel h/a x 2 days;pt exp asthma attack on 23OCT97 & 24OCT97;sx lasted 5 days;3rd dose not given-will titer;
a circular red rash made up of tiny bumps; area's slightly raised; injection site itself is still black & blue; felt really tired; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (felt really tired), INJECTION SITE RASH (a circular red rash made up of tiny bumps), INJECTION SITE SWELLING (area's slightly raised) and INJECTION SITE DISCOLOURATION (injection site itself is still black & blue) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced FATIGUE (felt really tired). On 11-Mar-2021, the patient experienced INJECTION SITE RASH (a circular red rash made up of tiny bumps), INJECTION SITE SWELLING (area's slightly raised) and INJECTION SITE DISCOLOURATION (injection site itself is still black & blue). At the time of the report, FATIGUE (felt really tired), INJECTION SITE RASH (a circular red rash made up of tiny bumps), INJECTION SITE SWELLING (area's slightly raised) and INJECTION SITE DISCOLOURATION (injection site itself is still black & blue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient took Ibuprofen before she got the injection.
Swelling and discomfort  inner aspect left arm, and present in left axilla and breast tissue.  Slightly red, intermittent itching.  Feels some numbness in left arm.